SPC
RCKT icon

Sigma Planning Corp’s Rocket Pharmaceuticals RCKT Stock Holding History

Sigma Planning Corp’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,575
Closed -$157K – 1326
2025
Q1 		$157K Buy
23,575
+200
+0.9% +$1.98K 0.01% 1137
2024
Q4 		$294K Sell
23,375
-1,500
-6% -$22.6K 0.01% 936
2024
Q3 		$459K Sell
24,875
-30
-0.1% -$614 0.01% 772
2024
Q2 		$536K Sell
24,905
-575
-2% -$13.2K 0.02% 694
2024
Q1 		$686K Buy
25,480
+13,610
+115% +$387K 0.02% 639
2023
Q4 		$356K Sell
11,870
-13,910
-54% -$307K 0.03% 578
2023
Q3 		$528K Sell
25,780
-307
-1% -$5.58K 0.02% 690
2023
Q2 		$518K Sell
26,087
-1,508
-5% -$30.5K 0.02% 721
2023
Q1 		$473K Buy
27,595
+1,275
+5% +$25K 0.02% 819
2022
Q4 		$515K Hold
26,320
– – 0.02% 752
2022
Q3 		$420K Buy
26,320
+5,030
+24% +$78.5K 0.02% 803
2022
Q2 		$293K Buy
21,290
+7,230
+51% +$86.2K 0.01% 1002
2022
Q1 		$223K Buy
+14,060
New +$243K 0.01% 1194

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return